Drugmakers are coming under scrutiny from federal regulators over the effects their medications may have on drivers while operating motor vehicles.
The Food and Drug Administration (FDA) announced Thursday it is looking to identify drugs that impair drivers' ability and increase their risk of being involved in a motor vehicle accident.
The FDA released a draft guidance aimed at helping drugmakers assess the risk psychoactive drugs pose to drivers and other people who share the road with them.
"Driving is a complex activity involving a wide range of cognitive, perceptual, and motor activities," the FDA wrote in the Federal Register.
"Reducing the incidence of motor vehicle accidents (MVAs) that occur because of drug-impaired driving is a public health priority," the agency added.
The FDA's draft guidance recommends manufacturers use a systematic approach to identify which drugs should be evaluated to determine what effects they would have on drivers.
The public has 60 days to comment on the draft guidance.